Jamie Takayesu, MD, on Genitourinary Cancer: Disparity in Physicians’ Assessment of Sexual Dysfunction in Women vs Men
Jamie Takayesu, MD, of the University of Michigan, discusses her findings on how frequently physicians are asking their female and male patients with genitourinary cancers about sexual dysfunction. Although 62.79% of women with genitourinary cancer who received brachytherapy thought they should be regularly asked about sexual function, just 13% of women, compared with 89% of men, were actually discussing sexual health with their providers. Even though brachytherapy is known to have a deleterious impact on sexual function, many women are not being monitored for this functional outcome as often as men. (Abstract 2306).